Skip to main content
. 2024 Oct 27;16(10):e70021. doi: 10.1111/1753-0407.70021

TABLE 1.

Clinical characteristics of the participants.

GC PGC p overall
N = 36 N = 36
Age (year) 31.9 (9.80) 31.1 (10.8) 0.733
Male 12 (33.3%) 15 (41.6%) 0.472
BMI (kg/m2) 20.66 (1.84) 21.25 (2.70) 0.285
TC (mmol/L) 4.75 (0.82) 4.80 (0.84) 0.779
TG (mmol/L) 0.79 (0.31) 0.79 (0.38) 0.922
HDLC (mmol/L) 1.57 (0.31) 1.56 (0.29) 0.897
LDLC (mmol/L) 2.69 (0.70) 2.89 (0.67) 0.226
HbA1c (%) 6.12 (0.50) 8.09 (1.52) <0.001
Fasting C peptide (nmol/L) 0.05 (0.06) 0.04 (0.05) 0.456
Islet autoantibodies (+) 21 (58.3%) 25 (69.4%) 0.462
GADA (+) 14 (38.9%) 22 (61.1%) 0.099
ZnT8A (+) 6 (16.7%) 6 (16.7%) 1.000
IA2A (+) 10 (27.8%) 10 (27.8%) 1.000
Age of onset (year) 19.97 (8.80) 18.39 (10.6) 0.492
Diabetes duration (year) 11.91 (5.74) 12.62 (6.61) 0.630
Alcohol (yes) 8 (22.2%) 15 (41.6%) 0.079
Smoking (yes) 2 (5.56%) 6 (16.67%) 0.260

Note: Data are presented as number (%) and median (interquartile range). The normal reference ranges for the clinical parameters mentioned are as follows: TC (3.6–5.2 mmol/L); TG (0.6–2.3 mmol/L); HDLC (≥1.0 mmol/L); LDLC (<3.4 mmol/L).

Abbreviations: BMI, body mass index; GADA, anti‐glutamic acid decarboxylase antibodies; HbA1c, hemoglobin A1c; HDLC, high‐density lipoprotein cholesterol; IA2A, insulinoma associated‐2 autoantibodies; LDLC, low‐density lipoprotein cholesterol; TC, total cholesterol; TG, triacylglycerol; ZnT8A, zinc transporter 8 autoantibodies.